Sawai Announces Listing of Two Generic Drugs with Three Strengths

Jun. 13. 2024

Osaka, Japan – June 13, 2024 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Motohiko Kimura) today announced the listing of two generic drugs with three strengths in the NHI (National Health Insurance) drug price list. Sawai’s product line now includes 327 compounds with 776 strengths.

The list of new products

1. Zonisamide OD Tablets TRE

Generic name Zonisamide
Strengths OD Tablets: 25mg, 50mg
Brand products TRERIEF®OD Tablets 25mg, 50mg

2. Zinc Acetate Granules

Generic name Zinc Acetate Hydrate
Strengths Granules: 5%
Brand products NOBELZIN®Granules 5%

The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.